Skip to main content

Table 3 The genotype distribution and the frequency of alleles of the PAI-1 4G/5G polymorphism in HCC and control groups

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

 

HCC patients (n = 50)

Control (n = 47)

OR (95% confidence interval)

p value

No.

%

No.

%

Genotype

 5G/5G

12

24.0

12

25.5

1 (reference)

Reference

 4G/4G

9

18.0

11

23.4

0.82 (0.25–2.69)

0.978

 4G/5G

29

58.0

24

51.1

1.21 (0.46–3.17)

0.890

 4G/4G + 4G/5G

38

76.0

35

74.5

1.08 (0.43–2.73)

0.952

Alleles

 5G

47

47

48

51.1

1 (reference)

 

 4G

53

53.0

46

48.9

1.17 (0.67–2.07)

0.673

  1. Chi-square test, OR odds ratio
  2. If p < 0.05 = not consistent with HWE